Literature DB >> 27184827

Severe pneumonitis after nivolumab treatment in a patient with melanoma.

Satoshi Watanabe1, Hideharu Kimura2, Hazuki Takato2, Yuko Waseda2, Johsuke Hara2, Takashi Sone2, Miki Abo2, Shintaro Maeda3, Takashi Matsushita3, Kazuo Kasahara2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27184827     DOI： 10.1016/j.alit.2016.04.009

Source DB:  PubMed          Journal:  Allergol Int        ISSN： 1323-8930            Impact factor:   5.836


× No keyword cloud information.
  9 in total

Review 1.  [Adverse effects of immunotherapy : Clinical aspects, radiological and nuclear medicine results].

Authors:  G Widmann; V A Nguyen; J Plaickner; W Jaschke
Journal:  Radiologe       Date:  2017-10       Impact factor: 0.635

2.  Successful treatment with low-dose nivolumab in refractory Hodgkin lymphoma after allogeneic stem cell transplantation.

Authors:  Makoto Onizuka; Minoru Kojima; Keiko Matsui; Shinichiro Machida; Masako Toyosaki; Yasuyuki Aoyama; Hidetsugu Kawai; Jun Amaki; Ryujiro Hara; Akifumi Ichiki; Yoshiaki Ogawa; Hiroshi Kawada; Naoya Nakamura; Kiyoshi Ando
Journal:  Int J Hematol       Date:  2017-01-17       Impact factor: 2.490

3.  Severe Pneumonitis after Nivolumab Treatment Accompanied by Acute Pulmonary Embolism in a Patient with Lung Adenocarcinoma.

Authors:  Ji-Ping Liao; Li-Gong Nie; Cheng-Li Que; Xiang-Dong Mu
Journal:  Chin Med J (Engl)       Date:  2017-11-20       Impact factor: 2.628

4.  Nivolumab-induced Acute Fibrinous and Organizing Pneumonia (AFOP).

Authors:  Tsukasa Ishiwata; Takahiro Ebata; Shunichiro Iwasawa; Jun Matsushima; Satoshi Ota; Yukio Nakatani; Kenji Tsushima; Yuji Tada; Koichiro Tatsumi; Yuichi Takiguchi
Journal:  Intern Med       Date:  2017-08-10       Impact factor: 1.271

Review 5.  Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy.

Authors:  Gerlig Widmann; Van Anh Nguyen; Julian Plaickner; Werner Jaschke
Journal:  Curr Radiol Rep       Date:  2017-09-11

Review 6.  Pharmacological interventions for melanoma: Comparative analysis using bayesian meta-analysis.

Authors:  Yang Yang; Jiaomiao Pei; Guozhen Gao; Zheng Yang; Shuzhong Guo; Bo Yue; Jianhua Qiu
Journal:  Oncotarget       Date:  2016-12-06

7.  Anti PD-1 immunotherapy related interstitial lung disease presenting as respiratory failure - A review with case series.

Authors:  Padmastuti Akella; Sundaravadivel Loganathan; Vishal Jindal; Jamal Akhtar; Amos Lal
Journal:  Respir Med Case Rep       Date:  2018-11-12

Review 8.  Imaging of Adverse Events Related to Checkpoint Inhibitor Therapy.

Authors:  Vanina Vani; Daniele Regge; Giovanni Cappello; Michela Gabelloni; Emanuele Neri
Journal:  Diagnostics (Basel)       Date:  2020-04-13

9.  Immune Checkpoint Inhibitor-Related Pulmonary Toxicity: Focus on Nivolumab.

Authors:  Hazim Bukamur; Heather Katz; Mohamed Alsharedi; Akram Alkrekshi; Yousef R Shweihat; Nancy J Munn
Journal:  South Med J       Date:  2020-11       Impact factor: 0.954
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.